How Early Supplier Partnership Strategies Support Cell Therapy Approvals

Why regulatory readiness is a shared journey — not a solo one When a cell therapy achieves FDA approval, the success story often gets told through the lens of clinical data. But behind every advanced therapy approval is a quieter, equally critical story shaped by manufacturing readiness, biopreservation strategy, and operational discipline. From our vantage […]